Shares of INC Research Holdings, Inc. (NASDAQ:INCR) have been given an average rating of “Hold” by the eleven research firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $62.25.

INCR has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of INC Research Holdings from a “sell” rating to a “hold” rating in a report on Friday, May 5th. Wells Fargo & Company cut shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 3rd. TheStreet upgraded shares of INC Research Holdings from a “c” rating to a “b-” rating in a report on Monday, April 17th. BidaskClub cut shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, KeyCorp upgraded shares of INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 target price for the company in a report on Monday, June 5th.

WARNING: “INC Research Holdings, Inc. (NASDAQ:INCR) Given Consensus Rating of “Hold” by Analysts” was first reported by American Banking News and is the property of of American Banking News. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/08/04/inc-research-holdings-inc-nasdaqincr-given-consensus-rating-of-hold-by-analysts.html.

In related news, CEO Alistair Macdonald sold 10,555 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $58.38, for a total transaction of $616,200.90. Following the transaction, the chief executive officer now owns 83,935 shares of the company’s stock, valued at $4,900,125.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Christopher L. Gaenzle sold 6,873 shares of the firm’s stock in a transaction that occurred on Friday, June 30th. The shares were sold at an average price of $58.32, for a total transaction of $400,833.36. Following the transaction, the chief accounting officer now directly owns 47,450 shares in the company, valued at approximately $2,767,284. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Envestnet Asset Management Inc. acquired a new position in shares of INC Research Holdings during the fourth quarter valued at $109,000. Invictus RG acquired a new position in shares of INC Research Holdings during the first quarter valued at $115,000. Foresters Investment Management Company Inc. acquired a new position in shares of INC Research Holdings during the first quarter valued at $128,000. Fifth Third Bancorp raised its position in shares of INC Research Holdings by 5.4% in the first quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock valued at $133,000 after buying an additional 149 shares during the last quarter. Finally, Ameritas Investment Partners Inc. acquired a new position in shares of INC Research Holdings during the first quarter valued at $164,000. 98.70% of the stock is currently owned by hedge funds and other institutional investors.

INC Research Holdings (INCR) traded down 0.27% during trading on Friday, hitting $55.35. 528,434 shares of the stock were exchanged. The stock’s 50-day moving average price is $57.78 and its 200-day moving average price is $51.67. INC Research Holdings has a 12-month low of $40.65 and a 12-month high of $61.10. The firm has a market cap of $3.00 billion, a PE ratio of 33.92 and a beta of 1.42.

INC Research Holdings (NASDAQ:INCR) last announced its earnings results on Thursday, July 27th. The company reported $0.64 EPS for the quarter, hitting the consensus estimate of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The company had revenue of $258.10 million during the quarter, compared to analysts’ expectations of $256.76 million. During the same period last year, the company posted $0.61 earnings per share. The business’s revenue for the quarter was down .3% on a year-over-year basis. On average, equities analysts expect that INC Research Holdings will post $2.58 EPS for the current year.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Analyst Recommendations for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.